MacroGenics Inc

Healthcare · Biotechnology

3.60$ -0.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

MacroGenics Inc (MGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 345 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGNX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	340	311	275	275	242	374	326	387	355	332	415	384	351	313	265	328	374	379	435	426	392	335	271	218	195	290	343	306	340	298	248	201	264	262	225	245	271	257	218	345
Current Assets	316	284	251	250	209	322	271	322	286	269	335	288	276	240	195	260	310	313	375	367	335	280	218	168	148	222	289	255	291	251	203	157	222	217	182	205	232	220	183	322
Cash	110	84	41	117	91	212	200	239	202	220	239	180	157	126	93	197	202	181	218	189	191	123	47	21	84	109	224	109	90	101	80	84	180	183	146	131	80	57	67	114
Cash & Short-Term Investments	311	277	243	244	204	305	260	301	260	233	320	272	254	216	171	233	281	273	343	297	299	244	184	134	124	154	242	240	256	230	184	140	200	202	154	176	146	190	154	173
Receivables	3.0	2.8	2.1	2.0	2.2	14	7.3	18	21	30	6.1	5.6	9.5	13	12	19	19	23	7.1	45	14	10	15	18	14	56	36	6.4	25	10	7.2	6.2	8.8	4.3	11	13	69	13	10	144
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	6.2	6.5	4.0	4.4	4.6	2.9	1.1	1.5	1.4	1.4	1.1	1.2	1.2	1.1	3.2	0.0	9.4	9.3	8.8	7.9	9.5	–
Property, Plant & Equipment	18	18	17	23	31	50	53	57	59	57	55	52	50	68	46	44	41	42	40	39	39	38	36	34	32	30	27	24	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	40	43	40	43	52	75	79	75	73	89	94	89	96	82	75	80	83	83	85	107	101	96	93	76	72	147	234	134	146	146	142	143	144	146	145	199	204	201	197	303
Current Liabilities	22	27	27	30	32	50	50	48	48	60	52	50	58	45	40	46	50	51	53	70	69	75	67	51	50	49	46	45	51	56	56	58	59	56	55	39	44	43	96	109
Short-Term Debt	1.5	1.6	1.5	1.1	0.7	0.3	31	38	39	34	3.7	3.6	3.0	3.0	3.1	3.4	3.8	4.0	4.2	4.4	4.5	4.7	4.8	4.9	5.0	4.7	4.4	4.2	3.9	3.8	4.1	4.4	4.7	4.9	5.4	5.1	5.1	5.2	5.2	5.0
Accounts Payable	1.4	4.0	1.5	2.1	1.7	2.5	10	1.8	1.0	4.0	0.9	0.9	2.5	4.3	2.0	2.8	4.4	8.0	10	9.8	6.2	16	3.7	2.6	4.6	4.9	3.8	3.8	3.3	6.4	11	5.2	6.6	5.0	6.6	4.7	5.9	4.8	4.3	3.4
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	25	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	300	269	235	231	189	299	247	312	283	243	321	294	255	231	191	248	292	296	351	319	291	240	178	142	123	142	109	172	194	153	106	58	120	116	79	47	67	56	21	43
Retained Earnings	-258	-293	-330	-371	-418	-312	-368	-412	-446	-490	-535	-567	-612	-642	-687	-734	-770	-772	-823	-863	-916	-974	-1,040	-1,082	-1,106	-1,094	-1,132	-1,074	-1,057	-1,103	-1,155	-1,211	-1,154	-1,170	-1,211	-1,247	-1,230	-1,244	-1,281	-1,262
Shares Outstanding	35	35	35	36	37	37	37	42	42	46	46	49	49	49	49	50	54	54	57	60	61	61	61	61	61	61	62	62	62	62	62	63	63	63	63	63	63	63	63	64

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings